|
|
|
|
|
Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: Yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment |
2563 |
# |
|
|
|
|
|
Distribution of pathogenic Naegleria spp in Thailand. |
2544 |
# |
|
|
|
|
|
Hydroxychloroquine treatment in SLE |
2558 |
# |
|
|
|
|
|
Receipt of Statins Is Associated With Lower Risk of Multiple Myeloma: Systematic Review and Meta-analysis |
2563 |
# |
|
|
|
|
|
Association between dietary patterns with disease recurrence in Thai colorectal cancer patients |
2562 |
# |
|
|
|
|
|
The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis. |
2560 |
# |
|
|
|
|
|
ALK-positive anaplastic large cell lymphoma undiagnosed in a patient with tuberculosis: a case report and review of the literature. |
2560 |
# |
|
|
|
|
|
Successful treatment of lethal cyanide ingestion by sodium thiosulfate alone: Case report |
2561 |
# |
|
|
|
|
|
Bullous Pemphigoid Treated With Intravenous Immunoglobulin |
2557 |
# |
|
|
|
|
|
A novel mutation of the IL12RB1 gene in a child with nocardiosis, recurrent salmonellosis and neurofibromatosis type I: first case report from Thailand. |
2552 |
# |
|
|
|
|
|
Findings from a large Asian chronic hepatitis C real-life study |
2561 |
# |
|
|
|
|
|
Preoperative Mapping of the Supplementary Motor Area in Patients with Brain Tumor Using Resting-State fMRI with Seed-Based Analysis. |
2561 |
# |
|
|
|
|
|
Inflammation to Pulmonary Diseases |
2559 |
# |
|
|
|
|
|
A pilot study of treatment of striae distensae with variable square pulse Erbium: YAG laser resurfacing. |
2560 |
# |
|
|
|
|
|
Agreement of evolution ASA-PS classification evaluated by anesthesia residents and research team and association with perioperative complications |
2562 |
# |
|
|
|
|
|
A Novel Missense Mutation in AE1 Causing Autosomal Dominant Distal Renal Tubular Acidosis Retains Normal Transport Function but Is Mistargeted in Polarized Epithelial Cells |
2547 |
# |
|
|
|
|
|
Association of HTTLPR and 5-HT2A T102C polymorphisms with smoking characteristics and anthropometric profiles of Thai males |
2555 |
# |
|
|
|
|
|
Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of Left Main Coronary Artery Disease Using Drug-Eluting Stents: Multicenter Registry in Asia |
2552 |
# |
|
|
|
|
|
MRI Predictors of Survival in Patients with Glioblastomas |
2558 |
# |
|
|
|
|
|
Cost-Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand |
2564 |
# |
|
|
|
|
|
Clinical and echocardiographic parameters and score for the left atrial thrombus formation prediction in the patients with mitral stenosis. |
2550 |
# |
|
|
|
|
|
Oral rehydration with 10% carbohydrate drink for preventing postoperative nausea and vomiting (PONV) after low dose of spinal morphine |
2557 |
# |
|
|
|
|
|
Application of immunoproteomics to leptospirosis: towards clinical diagnostics and vaccine discovery. |
2550 |
# |
|
|
|
|
|
A retrospective study of postdural puncture headache after spinal anesthesia for cesarean section treated by epidural blood patch: Incidence and associated factors |
2562 |
# |
|
|
|
|
|
A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection |
2559 |
# |
|
|
|
|
|
The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry |
2565 |
# |
|
|
|
|
|
Efficacy of a single 40-mg intravenous dose of parecoxib for postoperative pain control after elective cesarean delivery: A double-blind randomized placebo-controlled trial. |
2560 |
# |
|
|
|
|
|
Microfluidic system evaluation for the semi-automatic detection of MOG-IgG in serum samples |
2564 |
# |
|
|
|
|
|
Therapeutic Drug Monitoring of Lopinavir in HIV-Infected Children on Second-Line Antiretroviral Therapy in Asia. |
2559 |
# |
|
|
|
|
|
TREATMENT OF DECOMPESATED HBV-CIRRHOSIS: RESULTS FROM 2-YEARS RANDOMIZED TRIAL WITH TELBIVUDINE OR LAMIVUDINE |
2553 |
# |